Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 991 AL 1005

Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised

Fjell AM, Walhovd KB.

Mol Neurobiol. 2012 Feb;45(1):153-72. doi: 10.1007/s12035-011-8228-7. Epub 2011 Dec 27.

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

Banks WA.

Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.

Spines, plasticity, and cognition in Alzheimer's model mice

Spires-Jones T, Knafo S.

Neural Plast. 2012;2012:319836. doi: 10.1155/2012/319836. Epub 2011 Nov 28.

Brain insulin signaling and Alzheimer's disease: current evidence and future directions

Schiöth HB, Craft S, Brooks SJ, Frey WH 2nd, Benedict C.

Mol Neurobiol. 2012 Aug;46(1):4-10. doi: 10.1007/s12035-011-8229-6. Epub 2011 Dec 29.

Synaptic protein deficits are associated with dementia irrespective of extreme old age

Beeri MS, Haroutunian V, Schmeidler J, Sano M, Fam P, Kavanaugh A, Barr AM, Honer WG, Katsel P.

Neurobiol Aging. 2012 Jun;33(6):1125.e1-8. doi: 10.1016/j.neurobiolaging.2011.08.017. Epub 2011 Dec 27.

[Construction and validation of a scale to assess attitudes toward patients with Alzheimer's disease and related disorders]

Serrani D.

Rev Esp Geriatr Gerontol. 2012 Jan-Feb;47(1):5-14. doi: 10.1016/j.regg.2011.09.005. Epub 2011 Dec 29.

Assessing quality of life of older people with dementia: a comparison of quantitative self-report and proxy accounts

Moyle W, Murfield JE, Griffiths SG, Venturato L.

J Adv Nurs. 2012 Oct;68(10):2237-46. doi: 10.1111/j.1365-2648.2011.05912.x. Epub 2011 Dec 28.

The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits

Ye X, Tai W, Zhang D.

Neurobiol Aging. 2012 Jun;33(6):1122.e1-10. doi: 10.1016/j.neurobiolaging.2011.11.004. Epub 2011 Dec 31.

Vitamin A and Alzheimer's disease

Ono K, Yamada M.

Geriatr Gerontol Int. 2012 Apr;12(2):180-8. doi: 10.1111/j.1447-0594.2011.00786.x. Epub 2011 Dec 23.

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease

Anand P, Singh B, Singh N.

Bioorg Med Chem. 2012 Feb 1;20(3):1175-80. doi: 10.1016/j.bmc.2011.12.042. Epub 2011 Dec 30.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A.

Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14.

Genome-wide association analysis of age-at-onset in Alzheimer's disease

Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative; Sweet RA, Feingold E, DeKosky ST, Lopez OL.

Mol Psychiatry. 2012 Dec;17(12):1340-6. doi: 10.1038/mp.2011.135. Epub 2011 Oct 18.

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14.

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis

Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, Arrighi HM.

Neuroepidemiology. 2012;38(1):1-17. doi: 10.1159/000334607. Epub 2011 Dec 17.

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors

Tayeb HO, Yang HD, Price BH, Tarazi FI.

Pharmacol Ther. 2012 Apr;134(1):8-25. doi: 10.1016/j.pharmthera.2011.12.002. Epub 2011 Dec 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias